Plegridy

उत्पाद अवलोकन

About Plegridy

Plegridy is a prescription-only medication, and treatment should be started under the supervision of a doctor experienced in treating MS.

How it is used

Plegridy is available as an injection in pre-filled pens or pre-filled syringes, given every 2 weeks. The dose should be increased in two-week steps until the full dose is reached after 4 weeks. Plegridy is given by injection under the skin of the abdomen, the arm or the thigh, or by injection into the thigh muscle using a different type of syringe. Patients can inject Plegridy themselves, provided that they have been trained.

How it works

In MS, the immune system malfunctions and attacks parts of the central nervous system, causing inflammation that damages the nerves and the insulation around them. The exact way that Plegridy works in MS is not yet known but it seems to calm down the immune system, and prevents relapses of MS.

Active substance: peginterferon beta-1a, a protein that can be naturally produced by the body to help it fight against viruses and other attacks. In Plegridy, this interferon has been ‘pegylated’ (attached to a chemical called polyethylene glycol). This decreases the rate at which the medicine is removed from the body and allows it to be given less often.

Source: EMA EPAR